• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

369
65
48
46
19

COUNTRY

45
12
5
5
5

PRICE

296
549
1,001
1,436

PUBLISHED

104
126
494
1,436

PRODUCT TYPE

1,341
67
17
11

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Anesthetic Effect - Pipeline Review, H2 2014

Anesthetic Effect - Pipeline Review, H2 2014 Summary This, ‘Anesthetic Effect - Pipeline Review, H2 2014’, provides an overview of the Anesthetic Effect’s therapeutic pipeline. This report provides...

October 2014
FROM

Stroke - Pipeline Review, H2 2014

Stroke - Pipeline Review, H2 2014 Summary This, ‘Stroke - Pipeline Review, H2 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive information on the...

October 2014
FROM

Neuropathic Pain - Pipeline Review, H2 2014

Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This report provides...

October 2014
FROM

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Amyotrophic Lateral Sclerosis’s therapeutic...

October 2014
FROM
Imitrex-Drug Insights,2014 Imitrex-Drug Insights,2014 - Product Thumbnail Image

Imitrex-Drug Insights,2014

“Imitrex - Drug Insights, 2014” provides Imitrex marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

November 2014
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

October 2014
FROM

Partial Seizure - Pipeline Review, H2 2014

Partial Seizure - Pipeline Review, H2 2014 Summary This, ‘Partial Seizure - Pipeline Review, H2 2014’, provides an overview of the Partial Seizure’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing...

September 2014
FROM

Autism - Pipeline Review, H2 2014

Autism - Pipeline Review, H2 2014 Summary This, ‘Autism - Pipeline Review, H2 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

September 2014
FROM

Cognitive Impairment - Pipeline Review, H2 2014

Cognitive Impairment - Pipeline Review, H2 2014 Summary This, ‘Cognitive Impairment - Pipeline Review, H2 2014’, provides an overview of the Cognitive Impairment’s therapeutic pipeline. This report...

September 2014
FROM

Multiple Sclerosis - Pipeline Review, H2 2014

Multiple Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Multiple Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

September 2014
FROM

Cancer Pain - Pipeline Review, H2 2014

Cancer Pain - Pipeline Review, H2 2014 Summary This, ‘Cancer Pain - Pipeline Review, H2 2014’, provides an overview of the Cancer Pain’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014 Summary This, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014’, provides an overview of the Bipolar Disorder (Manic Depression)’s...

September 2014
FROM

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2014

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2014 Summary This, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2014’, provides an overview of the Attention...

September 2014
FROM

Cerebral Palsy - Pipeline Review, H2 2014

Cerebral Palsy - Pipeline Review, H2 2014 Summary This, ‘Cerebral Palsy - Pipeline Review, H2 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing Multiple Sclerosis...

September 2014
FROM

Sedation - Pipeline Review, H2 2014

Sedation - Pipeline Review, H2 2014 Summary This, ‘Sedation - Pipeline Review, H2 2014’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Dystonia - Pipeline Review, H2 2014

Dystonia - Pipeline Review, H2 2014 Summary This, ‘Dystonia - Pipeline Review, H2 2014’, provides an overview of the Dystonia’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM
Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers:  New Developments, Growth Areas and Opportunities - Product Thumbnail Image

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities

This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental minimally-invasive...

September 2014
FROM

Postherpetic Neuralgia - Pipeline Review, H2 2014

Postherpetic Neuralgia - Pipeline Review, H2 2014 Summary This, ‘Postherpetic Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline. This...

August 2014
FROM
Loading Indicator

Our Clients

Our clients' logos